E. Soya
E. Soya publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine, on topics such as Venous Thromboembolism Diagnosis and Management, Heart Failure Treatment and Management and Acute Myocardial Infarction Research.
- World rank
- #7,538,350 of 7,710,434 ranked researchers
- Rank in Côte d'Ivoire
- #1,623 of 1,695
- Works
- 42
- Citations
- 74
- Citations per work
- 1.8
What does E. Soya research?
E. Soya's work is mostly in Medicine (66%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2865.8%
- Medicine2865.8%
- Everything else1434.2%
- 1Cardiology and Cardiovascular Medicine26% of their works
- 2Surgery14% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Internal Medicine8% of their works
- 5Endocrinology, Diabetes and Metabolism6% of their works
- 6Epidemiology4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Blood Pressure and Hypertension Studies
- Diagnosis and Treatment of Venous Diseases
- Cardiovascular Health and Disease Prevention
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiac Imaging and Diagnostics
Which keywords describe E. Soya's research?
The keywords of their largest research topics: Cardiovascular Disease, Diagnosis, Treatment, Risk Factors, Clinical Practice Guidelines, Guidelines, Epidemiology and Myocardial Infarction.
- Metabolic Syndrome
- Diabetes
- Cardiac Imaging
- Varicose Veins
- Blood Pressure
- ST-Segment Elevation
- B-Type Natriuretic Peptide
- Venous Thromboembolism
- Cardiovascular Events
- Myocardial Infarction
- Guidelines
- Risk Factors
- Diagnosis
- Cardiovascular Disease
- Treatment
- Clinical Practice Guidelines
- Epidemiology
- Antithrombotic Therapy
- Hypertension
- Acute Coronary Syndromes
- Heart Failure
- Antihypertensive Drugs
- Chronic Venous Insufficiency
- Arterial Stiffness
- Coronary Artery Disease
- Endothelial Dysfunction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Cardiovascular Disease234 topics
- Diagnosis162 topics
- Treatment162 topics
- Risk Factors152 topics
- Clinical Practice Guidelines142 topics
- Guidelines142 topics
- Epidemiology122 topics
- Myocardial Infarction102 topics
- Antithrombotic Therapy91 topic
- Cardiovascular Events92 topics
- Hypertension92 topics
- Venous Thromboembolism91 topic
- Acute Coronary Syndromes71 topic
- B-Type Natriuretic Peptide71 topic
- Heart Failure71 topic
- ST-Segment Elevation71 topic
- Antihypertensive Drugs61 topic
- Blood Pressure61 topic
- Chronic Venous Insufficiency51 topic
- Varicose Veins51 topic
- Arterial Stiffness31 topic
- Cardiac Imaging31 topic
- Coronary Artery Disease31 topic
- Diabetes31 topic
- Endothelial Dysfunction31 topic
- Metabolic Syndrome31 topic
Where does E. Soya work?
E. Soya's main affiliation in the publication record is Institut Universitaire d'Abidjan, Côte d'Ivoire.
How many publications and citations does E. Soya have?
OpenAlex counts 42 works and 74 citations for E. Soya, an h-index of 4, ranking #7,538,350 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about E. Soya. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.